Seite - (000204) - in Biomedical Chemistry: Current Trends and Developments

NINDS (1995). Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. New England Journal of Medicine, 333(24), 1581-1587. Niswender, C. M. and P. J. Conn (2010). Metabotropic glutamate receptors: physiology, pharmacology, and disease. Annual Reviews in Pharmacology & Toxicology, 50, 295-322. Nitsche, M. A., L. G. Cohen, et al. (2008). Transcranial direct current stimulation: State of the art 2008. Brain Stimulation, 1(3), 206-223. Noel, X., D. Brevers, et al. (2013). A neurocognitive approach to understanding the neurobiology of addiction. Current Opinion in Neurobiology, 23(4), 632-638. Obrenovitch, T. P. (2008). Molecular physiology of preconditioning-induced brain tolerance to ischemia. Physiological Reviews, 88(1), 211-247. Owens, D. F. and A. R. Kriegstein (2002). Is there more to GABA than synaptic inhibition? Nature reviews. Neuroscience, 3(9), 715-727. Paciaroni, M., V. Caso, et al. (2009). The concept of ischemic penumbra in acute stroke and therapeutic opportunities. European Neurology, 61(6), 321-330. Palop, J. J. and L. Mucke (2010). Amyloid-beta-induced neuronal dysfunction in Alzheimer’s disease: from synapses toward neural networks. Nature Neuroscience, 13(7), 812-818. Parameshwaran, K., M. Dhanasekaran, et al. (2008). Amyloid beta peptides and glutamatergic synaptic dysregulation. Experimental Neurology, 210(1), 7-13. Peng, P. L., X. Zhong, et al. (2006). ADAR2-dependent RNA editing of AMPA receptor subunit GluR2 determines vulnerability of neurons in forebrain ischemia. Neuron, 49(5), 719-733. Perreault, M. L., B. F. O’Dowd, et al. (2014). Dopamine D(1)-D(2) receptor heteromer regulates signaling cascades involved in addiction: potential relevance to adolescent drug susceptibility. Developmental Neuroscience, 36(3-4), 287-296. Pierri, J. N., A. S. Chaudry, et al. (1999). Alterations in chandelier neuron axon terminals in the prefrontal cortex of schizophrenic subjects. The American Journal of Psychiatry, 156(11), 1709-1719. Pin, J. P. and F. Acher (2002). The metabotropic glutamate receptors: structure, activation mechanism and pharmacology. Current Drug Targets CNS Neurologic Disorders, 1(3), 297- 317. Pinard, A., R. Seddik, et al. (2010). GABAB receptors: physiological functions and mechanisms of diversity. Advances in pharmacology, 58, 231-255. Pineyro, G. and P. Blier (1999). Autoregulation of serotonin neurons: role in antidepressant drug action. Pharmacology Reviews, 51(3), 533-591. Plitman, E., S. Nakajima, et al. (2014). Glutamate-mediated excitotoxicity in schizophrenia: A review. European Neuropsychopharmacology, 24(10), 1591-1605. Porras, G., V. Di Matteo, et al. (2002). 5-HT2A and 5-HT2C/2B receptor subtypes modulate dopamine release induced in vivo by amphetamine and morphine in both the rat nucleus accumbens and striatum. Neuropsychopharmacology, 26(3), 311-324. Prybylowski, K. and R. J. Wenthold (2004). N-Methyl-D-aspartate receptors: subunit assembly and trafficking to the synapse. Journal of Biology & Chemistry, 279(11), 9673-9676. Puig, M. V., J. Rose, et al. (2014). Dopamine modulation of learning and memory in the prefrontal cortex: insights from studies in primates, rodents, and birds. Frontiers in Neural Circuits, 8,